Usana Health Sciences Stock Buy Hold or Sell Recommendation
| USNA Stock | USD 34.02 0.10 0.29% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding USANA Health Sciences is 'Strong Hold'. Macroaxis provides USANA Health buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding USNA positions.
Check out USANA Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as USANA and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards USANA Health Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
USANA |
Execute USANA Health Buy or Sell Advice
The USANA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on USANA Health Sciences. Macroaxis does not own or have any residual interests in USANA Health Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute USANA Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
USANA Health Trading Alerts and Improvement Suggestions
| USANA Health generated a negative expected return over the last 90 days | |
| About 58.0% of the company outstanding shares are owned by institutional investors | |
| Latest headline from zacks.com: Is USANA Health Sciences Stock Undervalued Right Now |
USANA Health Returns Distribution Density
The distribution of USANA Health's historical returns is an attempt to chart the uncertainty of USANA Health's future price movements. The chart of the probability distribution of USANA Health daily returns describes the distribution of returns around its average expected value. We use USANA Health Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of USANA Health returns is essential to provide solid investment advice for USANA Health.
| Mean Return | -0.04 | Value At Risk | -3.83 | Potential Upside | 3.46 | Standard Deviation | 2.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of USANA Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
USANA Stock Institutional Investors
| Shares | Ubs Group Ag | 2024-09-30 | 184.8 K | Charles Schwab Investment Management Inc | 2024-09-30 | 179 K | Assenagon Asset Management Sa | 2024-09-30 | 124 K | Northern Trust Corp | 2024-09-30 | 116.7 K | Jacobs Levy Equity Management, Inc. | 2024-09-30 | 110.5 K | Citadel Advisors Llc | 2024-09-30 | 107.8 K | Amvescap Plc. | 2024-09-30 | 95.5 K | Ameriprise Financial Inc | 2024-09-30 | 93.6 K | Bank Of New York Mellon Corp | 2024-09-30 | 89.1 K | Blackrock Inc | 2024-09-30 | 1.8 M | Vanguard Group Inc | 2024-09-30 | 1.6 M |
USANA Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (16.8M) | (10.5M) | 21.9M | 2.4M | 2.7M | 2.8M | |
| Change In Cash | 78.2M | (72.3M) | 47.7M | 41.9M | 48.2M | 50.6M | |
| Free Cash Flow | 145.3M | 108.5M | 93.5M | 56.1M | 64.6M | 60.9M | |
| Depreciation | 22.5M | 22.2M | 21.4M | 20.4M | 23.5M | 24.6M | |
| Other Non Cash Items | 701K | 61K | 141K | 2.6M | 2.3M | 2.5M | |
| Capital Expenditures | 15.1M | 12.8M | 10.4M | 14.5M | 16.7M | 12.3M | |
| Net Income | 124.7M | 116.5M | 69.4M | 63.8M | 73.4M | 55.4M | |
| End Period Cash Flow | 315.9M | 243.7M | 291.3M | 333.2M | 383.2M | 402.4M | |
| Change To Netincome | 12.0M | 12.7M | 11.4M | 6.3M | 7.2M | 12.6M | |
| Investments | (18.9M) | (1.4M) | (12.4M) | (7.9M) | (7.1M) | (6.8M) |
USANA Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to USANA Health or Personal Care Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that USANA Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a USANA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.50 | |
σ | Overall volatility | 2.42 | |
Ir | Information ratio | -0.03 |
USANA Health Volatility Alert
USANA Health Sciences exhibits very low volatility with skewness of 0.56 and kurtosis of 1.27. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure USANA Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact USANA Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.USANA Health Fundamentals Vs Peers
Comparing USANA Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze USANA Health's direct or indirect competition across all of the common fundamentals between USANA Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as USANA Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of USANA Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing USANA Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare USANA Health to competition |
| Fundamentals | USANA Health | Peer Average |
| Return On Equity | 0.11 | -0.31 |
| Return On Asset | 0.0809 | -0.14 |
| Profit Margin | 0.06 % | (1.27) % |
| Operating Margin | 0.08 % | (5.51) % |
| Current Valuation | 283.52 M | 16.62 B |
| Shares Outstanding | 19.06 M | 571.82 M |
| Shares Owned By Insiders | 41.70 % | 10.09 % |
| Shares Owned By Institutions | 57.56 % | 39.21 % |
| Number Of Shares Shorted | 454.17 K | 4.71 M |
| Price To Earning | 8.70 X | 28.72 X |
| Price To Book | 1.21 X | 9.51 X |
| Price To Sales | 0.75 X | 11.42 X |
| Revenue | 921.01 M | 9.43 B |
| Gross Profit | 697 M | 27.38 B |
| EBITDA | 123.11 M | 3.9 B |
| Net Income | 63.79 M | 570.98 M |
| Cash And Equivalents | 246.88 M | 2.7 B |
| Cash Per Share | 12.82 X | 5.01 X |
| Total Debt | 13.21 M | 5.32 B |
| Debt To Equity | 0.06 % | 48.70 % |
| Current Ratio | 2.71 X | 2.16 X |
| Book Value Per Share | 27.98 X | 1.93 K |
| Cash Flow From Operations | 70.64 M | 971.22 M |
| Short Ratio | 3.70 X | 4.00 X |
| Earnings Per Share | 2.82 X | 3.12 X |
| Price To Earnings To Growth | 0.91 X | 4.89 X |
| Target Price | 51.5 | |
| Number Of Employees | 1.8 K | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 650.31 M | 19.03 B |
| Total Asset | 632.76 M | 29.47 B |
| Retained Earnings | 445.22 M | 9.33 B |
| Working Capital | 298.9 M | 1.48 B |
Note: Disposition of 4847 shares by Joshua Foukas of USANA Health at 47.913 subject to Rule 16b-3 [view details]
USANA Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as USANA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About USANA Health Buy or Sell Advice
When is the right time to buy or sell USANA Health Sciences? Buying financial instruments such as USANA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having USANA Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Real Estate Thematic Idea Now
Real Estate
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
| View All Next | Launch |
Check out USANA Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Earnings Share 2.82 | Revenue Per Share | Quarterly Revenue Growth (0.06) | Return On Assets |
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.